The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.
Adult (aged >18 years) MSK patients as per the EHR
Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
Must be English-speaking in the EHR
Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report
Single group
Indoor Air Quality Monitor AirGradient ONE
Other interventionParticipants will be asked to set up an Indoor Air Quality Monitor AirGradient ONE (Model: I-9PSL) which is an award winning commercially available indoor air quality monitor designed to enable anyone to monitor their air quality in their home for about 60 days (8 weeks). Indoor air pollution levels within participating households will be measured using these AQMs.
Percentage of participants using the air quality monitoring device for 14 consecutive days
Assess the feasibility and acceptability of collecting environmental data on biomarkers of household air quality (AQ) and smoke exposure using low-cost, AQMs as an intermediate endpoint of a smoke-free-home.
Percentage of participants who attend the study-specific smoke-free workshop sessions
Assess the feasibility and acceptability of tobacco treatment adherence among individuals diagnosed with cancer.
Click on the lead sponsor to view all of their trials.
